Related Experiment Video
Updated: Jul 15, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
Special airway concerns in patients with mucopolysaccharidoses
H Steven Sims1, James J Kempiners
1Chicago Institute for Voice Care, University of Illinois at Chicago, IL 60612, USA. voicecare@uic.edu
Abstract:
The mucopolysaccharidoses are comprised of hereditary disorders joined by errant degradation of mucopolysaccharides. The relatively infrequent opportunity to care for these patients is evidenced by a fairly small number of case reports and anecdotal information. Though lifespan is increasing, onset of respiratory pathology or involvement remains portentous. We present two cases that punctuate the need for insightful decision making while managing the airway for these patients.
Insights
Mucopolysaccharidoses are rare genetic disorders affecting mucopolysaccharide breakdown. Managing airway complications in these patients requires careful decision-making due to potential respiratory issues.
Area of Science:
- Medical Genetics
- Biochemistry
- Pulmonology
Background:
- Mucopolysaccharidoses (MPS) are a group of rare inherited metabolic disorders.
- These conditions result from deficiencies in enzymes responsible for degrading mucopolysaccharides (glycosaminoglycans).
- Accumulation of mucopolysaccharides leads to progressive cellular damage affecting multiple organ systems.
Observation:
- Patients with MPS often present with complex airway challenges.
- Respiratory pathology, including upper and lower airway obstruction, is a significant concern.
- Despite increased lifespan, airway management remains a critical aspect of patient care.
Findings:
- This report details two cases highlighting the complexities of airway management in MPS patients.
- Effective airway management necessitates informed decision-making and tailored strategies.
- Early recognition and intervention for respiratory compromise are crucial.
Implications:
- These cases underscore the importance of specialized knowledge for managing MPS-related airway issues.
- Improved understanding can lead to better clinical protocols and patient outcomes.
- Further research into airway management techniques for MPS is warranted.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Breathing
